Paragon Biosciences Qlarity Capital
Chicago, US · Founded 2018 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
DP
Darien ParhadNamed on SEC filing
JS
Jeffrey S. AroninNamed on SEC filing
PJ
Patrick J. MorrisNamed on SEC filing
Board
AJ
Antonio J. GraciasinBoard directorFounder, Chief Executive Officer & Chief Investment Officer at Valor Equity Partners
Investors · 1
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2019
▶$15MraisedNov 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedNov 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Darien ParhadExecutive Officer
- Jeffrey S. AroninDirector
- Antonio J. GraciasDirector
- Patrick J. MorrisExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- Minimum investment
- $15M
- Sales commissions
- $450K
- Placement agents
- Paragon Health Capital, LLC
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Paragon Biosciences Qlarity Capital's investors?
- Paragon Biosciences Qlarity Capital's investors include Valor Equity Partners.
- How much funding has Paragon Biosciences Qlarity Capital raised?
- Paragon Biosciences Qlarity Capital has disclosed $15M raised across 1 round.
- Where is Paragon Biosciences Qlarity Capital headquartered?
- Paragon Biosciences Qlarity Capital is headquartered in Chicago, US.